• Text Size :
    • -
    • +

The 16th Mexico-Japan Endoscopy Conference

Program
Mailing List
Connection Information
Files
Report
ver 1.75

The 16th Mexico-Japan Endoscopy Conferencereload

Local Time at Main Venue 2018.12.11(Tue) 18:00 - 60min, Mexico City, MX (UTC-06:00)
Organizer Miguel Tanimoto
Topic Clinical characteristics of gastric cancer discovered after H. pylori eradication
Contents Endoscopy
Style Conference
Connection Method Vidyo, Telepointer, Streaming
Server At Kyushu University
Access Information
Brief Description Helicobacter pylori infection is the most important risk factor for gastric cancer, for which eradication therapy is commonly performed. However, gastric cancer is sometimes discovered after successful eradication of H. pylori.

Key Members

ChairMiguel TanimotoThe National Institute of Medical Sciences and NutritionMX
Co-Chair 1---
Co-Chair 2---
Chief Engineer 1Shunta TomimatsuKyushu University HospitalJP
Chief Engineer 2Mayuko OkadaKyushu University HospitalJP
Chief Engineer 3Eyitayo Adeniyi AdebayoRome Business SchoolIT
Chief Engineer 4---

Connecting Institutions  

Red is to be decided
City, Country Institution Moderator Local Engineer
1(Main).Mexico City, MXThe National Institute of Medical Sciences and NutritionMiguel TanimotoNancy Gertrudiz
2.Fukuoka, JPKyushu University HospitalTomohiko MoriyamaShunta Tomimatsu

Schedule

Main venue     Localtime
1.Mexico City, MX
(UTC-06:00)
ContentsPresenterUTC+09:00
(Institution No. 2)
2018.12.11
17:30 - 18:00
2018.12.12
08:30 - 09:00
18:00 - 18:10Opening remarks and greetingsMiguel Tanimoto(The National Institute of Medical Sciences and Nutrition)09:00 - 09:10
18:10 - 18:50Clinical characteristics of gastric cancer discovered after H. pylori eradicationTomohiko Moriyama(Kyushu University Hospital)09:10 - 09:50
18:50 - 19:00Closing remarksMiguel Tanimoto(The National Institute of Medical Sciences and Nutrition)09:50 - 10:00

Precautions

  • The conference will be recorded by the photos and movies.
  • Pictures taken at the conference will be published in TEMDEC home page, annual report and conference presentations.
  • Do not present the personal information of patients any in oral and presentation materials without obtaining the patient's consent.

* For more information, please refer to the TEMDEC policy.